Tumor Response Criteria in Oncoimaging: RECIST Criteria and beyond—Part 1
نویسندگان
چکیده
منابع مشابه
RECIST criteria: our experience in daily practice
Content organisation Our cases will be presented in a pictorial essay mode. Key differential diagnostic points will be highlighted in the discussion of each case. It is important to consider: Complete knowledge of clinical-oncologic status and treatments time points. Recognition of smallest measured value (NADIR) between time points for adequate selection of comparative review. Sum of target le...
متن کاملThe RECIST criteria: implications for diagnostic radiologists
Monitoring response of tumours to treatment is an integral and increasingly important function of radiologists working in oncological imaging. Imaging studies play a pivotal, objective role in quantifying tumour response to a variety of physical and pharmaceutical treatments. Objective tumour shrinkage has been widely adopted as a standard end-point to select new anti-cancer drugs for future st...
متن کاملResponse assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: comparative analysis of the Macdonald, RECIST, RANO, and RECIST + F criteria.
Traditionally, the most widely used criteria for response assessment in glioblastoma have been Macdonald and the Response Evaluation Criteria In Solid Tumors (RECIST). Recently, new criteria addressing contrast enhancement and fluid-attenuated inversion recovery (FLAIR)/T2 hyperintensity have been defined (the Response Assessment in Neuro-Oncology criteria) to better evaluate the effect of anti...
متن کاملTumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602
BACKGROUND Two standard sets of criteria are used to evaluate the tumor response of hepatocellular carcinoma (HCC): RECIST (Response Evaluation Criteria in Solid Tumors) and modified RECIST (mRECIST). The purpose was to compare two tumor response evaluation criteria, RECIST version 1.1 and mRECIST, for HCC treated using transcatheter arterial chemoembolization (TACE). METHODS The radiological...
متن کامل'Please, desist RECIST criteria in GIST, at least in me'.
for 2 months. A control CT showed central necrosis of the lesions which were essentially unchanged. However, the patient reported that the symptom of abdominal pain did no longer exist. The patient was advised to take imatinib mesylate for 2 more months. A subsequent CT scan again showed no change in the diameter of the mass, so the RECIST criteria again failed to meet our expectations. As a co...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Gastrointestinal and Abdominal Radiology
سال: 2019
ISSN: 2581-9178
DOI: 10.1055/s-0039-1692021